Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7781924 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL1479492 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL10824102 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL16007698 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL1479592 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL10346980 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL1479595 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL7775081 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL7775084 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR | |
| SCHEMBL7781921 | 1.00 | NAAA (0.48) | NAAANOD1EPHX1FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118662369-A | Crease-resistant skin care composition containing organic nitrate and preparation method thereof | 瑞思益特(江西)生物科技开发有限公司 | 2024-09-20 | — | — | CN | claimed |
| WO-2008094846-A1 | REVERSIBLE ROOM-TEMPERATURE IONIC LIQUIDS | GEORGETOWN UNIVERSITY (US) | 2008-08-07 | — | — | WO | claimed |
| CN-118662369-A | Crease-resistant skin care composition containing organic nitrate and preparation method thereof | 瑞思益特(江西)生物科技开发有限公司 | 2024-09-20 | — | — | CN | disclosed |
| WO-2024062180-A1 | BIOSOURCED ORGANOGELATORS AND ORGANOGELS CONTAINING SAME | SORBONNE UNIVERSITE (FR) | 2024-03-28 | — | — | WO | disclosed |
| CN-110305030-B | Amino acid ester hydrochloride and preparation method and application thereof | 昆明理工大学 | 2021-10-15 | — | — | CN | disclosed |
| CN-110305030-A | Amino acid ester hydrochlorides and the preparation method and application thereof | 昆明理工大学 | 2019-10-08 | — | — | CN | disclosed |
| US-9433895-B2 | Reversible room-temperature ionic liquids | GEORGETOWN UNIVERSITY (US) | 2016-09-06 | — | — | US | disclosed |
| US-20140120013-A1 | Reversible Room-Temperature Ionic Liquids | GEORGETOWN UNIVERSITY (US) | 2014-05-01 | — | — | US | disclosed |
| US-8574453-B2 | Reversible room-temperature ionic liquids | GEORGETOWN UNIVERSITY (US) | 2013-11-05 | — | — | US | disclosed |
| US-20110076214-A1 | Reversible Room-Temperature Ionic Liquids | Georgetown University Office of Technology Commercialization (US) | 2011-03-31 | — | — | US | disclosed |
| US-7645805-B2 | Gelling agents | APPLIED NANOSYSTEMS, B.V. (NL) | 2010-01-12 | — | — | US | disclosed |
| WO-2003097587-A2 | GELLING AGENTS | APPLIED NANOSYSTEMS B.V. (NL) | 2003-11-27 | — | — | WO | disclosed |
| EP-1364941-A1 | Gelling agents | Applied NanoSystems B.V. (NL) | 2003-11-26 | — | — | EP | disclosed |
| US-6566494-B1 | Solid support for use in the generation of preferential peptides | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2003-05-20 | — | — | US | disclosed |
| US-5917015-A | Support material for solid phase organic synthesis | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-06-29 | — | — | US | disclosed |
| EP-0532664-B1 | SUPPORTED CHIRAL LIQUID MEMBRANE FOR THE SEPARATION OF ENANTIOMERS | RES CORP TECHNOLOGIES INC (US) | 1996-02-14 | — | — | EP | disclosed |
| EP-0532664-A4 | SUPPORTED CHIRAL LIQUID MEMBRANE FOR THE SEPARATION OF ENANTIOMERS | — | 1993-03-31 | — | — | EP | disclosed |
| EP-0532664-A1 | SUPPORTED CHIRAL LIQUID MEMBRANE FOR THE SEPARATION OF ENANTIOMERS. | RES CORP TECHNOLOGIES INC (US) | 1993-03-24 | — | — | EP | disclosed |
| WO-1991017816-A1 | SUPPORTED CHIRAL LIQUID MEMBRANE FOR THE SEPARATION OF ENANTIOMERS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-11-28 | — | — | WO | disclosed |
| US-4565643-A | PROTEIN CONTAINING AMINO ACID ESTER | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1986-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110076214-A1 | Reversible Room-Temperature Ionic Liquids | TRMT1L, TRRAP, RCOR3 | NAAA 3340/4885NOD1 1483/4885EPHX1 1753/4885 |
| US-20140120013-A1 | Reversible Room-Temperature Ionic Liquids | TRMT1L, TRRAP, RCOR3 | NAAA 3340/4885NOD1 1483/4885EPHX1 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.